Viewing Study NCT02160951


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-05-30 @ 5:30 AM
Study NCT ID: NCT02160951
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2014-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma, View
None Phase I, View
None PIM, View
None Japanese patients, View
None LGH447 View